16 records found.
Nov 04, 2019
Sickle Cell Disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Aug 13, 2019
A Platform for Screening Drugs To Treat Sickle Cell Disease Now Offered by ReachBio Research Labs
Jun 19, 2019
On World Sickle Cell Day, Medunik USA highlights the importance of early treatment of Sickle Cell Disease
Jun 18, 2019
Arix Bioscience plc: Imara Presents initial Phase 2a data for IMR-687
Apr 09, 2019
Medunik USA expands access to Siklos® for pediatric sickle cell anemia patients by offering 340B pricing to covered entities through Apexus
Dec 01, 2018
Studies Show Improved Sickle Cell Disease Outcomes Worldwide
Dec 01, 2018
Sickle Cell Anemia Treatment Safely Lowers Disease Burden in African Children
Dec 01, 2018
Novartis announces new crizanlizumab (SEG101) data analysis in sickle cell disease, and investment in SENTRY clinical program
Nov 19, 2018
Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in 1,000 mg triple-scored tablets to help optimize dosing
Nov 15, 2018
Sickle Cell Disease Treatment Market Worth $5.5 Billion by 2023 | CAGR: 14.3%: Grand View Research, Inc.
Oct 09, 2018
Novartis analysis shows crizanlizumab (SEG101) increased the number of patients free of sickle cell pain crises vs placebo during SUSTAIN study
Sep 12, 2018
Siklos® (hydroxyurea) now available through ProCare Pharmacy Care's Siklos At Home(TM) program
Aug 21, 2018
Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in retail pharmacies
May 23, 2018
Sickle Cell Anemia: Global Drug Market Outlook to 2024 - A $350 Million Market Opportunity
Dec 11, 2017
Novartis drug crizanlizumab shown to prolong time to patients' first sickle cell pain crisis in subgroup analysis of SUSTAIN study
Oct 19, 2017
Study: Sickle Cell Anemia Treatment Does Not Increase Malaria Risk in Africa